Leads Biolabs, LBL-034, LeadsBody Platform, Multiple Myeloma, Relapsed/Refractory Multiple Myeloma, RRMM, GPRC5D, CD3, T-Cell Engager, TCE, Bispecific Antibody

NANJING, China — October 25, 2026 Leads Biolabs (HKEX: 9887) announced updated first-in-human clinical results for LBL-034, an investigational...